个人简介

Personal Profile

宫恩莹，中国医学科学院北京协和医学院群医学及公共卫生学院研究员，博士生导师。本科毕业于北京大学医学部，硕士毕业于美国杜克大学全球健康专业，博士毕业于澳大利亚墨尔本大学人口与全球健康学院。于2021年8月加入群医学及公共卫生学院，主要开展慢性病流行病学、实施科学、数字健康干预、群医学等领域的研究与教学工作。近5年主持或参与多项国家科技创新重大项目、重点研发计划、基础资源项目、国家自然科学基金项目、美国中华医学会公开竞标项目、世界卫生组织咨询项目、工程院咨询项目。研究重点关注人群重大慢性疾病及共病防控、数字健康、主动健康及整合型健康照护模式等领域。在包括the BMJ、Lancet Digital Health, Circulation, PLOS Medicine，JAMA Network，Journal of Medical Internet Research等杂志发表SCI文章50余篇，参编专著2本。 Dr.Enying Gong is a public health researcher who joined the School of Population Medicine and Public Health in 2021. She has dedicated in research and education in the area of epidemiological research, implementation science, digital health, and population medicine. She received bachelor degree at Peking University, MSc degree at Duke University and PhD at the University of Melbourne. She has served as the principal investigator or co-investigator on numerous national and international projects funded by the National Science Foundation of China, National Key R&D Program of China, China Medical Board Open Competition, World Health Organization, etc. Dr.Gong is dedicated to translating high-quality research evidence into public health practices with particular expertise in implementation science and she served as junior faculty member of the Implementation Science School for Global Alliance for Chronic Diseases. She actively collaborates with researchers, public health practitioners and policy makers at local, national and global level to promote evidence-based interventions that improve chronic disease outcomes and advance health equity. Enying has published over 50 peer-reviewed papers in leading journals, including the BMJ, Circulation, Lancet Digital Health, PLOS Medicine, JAMA network open, etc.

团队简介

Team Profile

本团队依托中国医学科学院/北京协和医学院的顶尖科研平台，致力于慢性病流行病学、数字健康干预与实施科学的创新研究。研究团队以改善人群健康为目标，通过流行病学、实施科学的前沿方法、行为健康理论、数字健康技术的深度融合，推动重大慢性病及共病的病因探索、干预创新和实践转化。研究团队重点关注内容包括： （1）慢性病共病流行病学研究：依托医科院科研平台及队列资源，开展人群慢病共病研究，聚焦于共病流行特征与聚类模式、多元交互因素对疾病发生发展的协同影响，老年人内在能力与衰弱等领域；代表性成果发表于the BMJ， BMC Geriatrics等杂志。 （2）慢性病干预及实施性研究：依托丰富的群医学实践基地，开展人群慢性病干预及实施科学研究，重点关注已有循证策略在社区、医疗机构等不同场景的实施转化，提升医疗照护质量，推动人群健康。代表性成果发表于PLOS Medicine, JAMA Network Open等杂志。 （3）数字健康干预：重点关注数字健康技术及智慧化防控策略在慢性病防控中的有效应用，开展基于行为健康理论与数字化干预技术的前沿探索，代表性研究成果发表于the BMJ, Lancet Digital Health, Journal of Medical Internet Research等杂志。 团队与国内顶尖科研、临床团队合作，致力于创造多学科交叉的创新研究环境，建立广泛国内外合作网络。热忱欢迎对慢性病流行病学、数字健康、人群健康大数据、群医学等领域的优秀人才加入。欢迎有相关兴趣/背景的学生报考，也诚邀博士后、科研助理、实习生加入团队，欢迎详谈。 Prof. Gong’s group is dedicated to transforming population health outcomes in chronic disease prevention and control through innovative digital health solutions and implementation science methodologies. The team strives to bridge gaps in healthcare quality and population health outcomes by generating evidence-based strategies, fostering interdisciplinary collaboration, and empowering communities with scalable and equitable interventions. We are looking forward to collaborating with international researchers and practitioners in the research area of NCDs prevention and management, multimorbidity and healthy aging research, digital health and implementation science area.